BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 5751426)

  • 1. The chemotherapy of rodent malaria. II. Host-parasite relationships. 2. The relationship between chloroquine sensitivity and the age of the host cell.
    Peters W
    Ann Trop Med Parasitol; 1968 Jun; 62(2):246-61. PubMed ID: 5751426
    [No Abstract]   [Full Text] [Related]  

  • 2. The chemotherapy of rodent malaria. I. Host-parasite relationships. I. The virulence of infection in relation to drug resistance and time elapsed since isolation of the 'wild' strain.
    Peters W
    Ann Trop Med Parasitol; 1968 Jun; 62(2):238-45. PubMed ID: 5709223
    [No Abstract]   [Full Text] [Related]  

  • 3. The chemotherapy of rodent malaria. X. Dynamics of drug resistance. II. Acquisition and loss of chloroquine resistance in Plasmodium berghei observed by continuous bioassay.
    Peters W
    Ann Trop Med Parasitol; 1970 Mar; 64(1):25-40. PubMed ID: 5485708
    [No Abstract]   [Full Text] [Related]  

  • 4. The chemotherapy of rodent malaria. XI. Cyclically transmitted, chloroquine-resistant variants of the Keyberg 173 strain of Plasmodium berghei.
    Peters W; Bafort J; Ramkaran AE
    Ann Trop Med Parasitol; 1970 Mar; 64(1):41-51. PubMed ID: 5485709
    [No Abstract]   [Full Text] [Related]  

  • 5. The chemotherapy of rodent malaria. 3. Host-parasite relationships. 3. The relationship between haemozoin formation and the age of the host cell.
    Howells RE; Peters W; Thomas EA
    Ann Trop Med Parasitol; 1968 Sep; 62(3):267-70. PubMed ID: 5714953
    [No Abstract]   [Full Text] [Related]  

  • 6. The chemotherapy of rodent malaria. IV. Host-parasite relationships. 4. The relationship between haemozoin formation and host-cell age in chloroquine- and primaquine-resistant strains of Plasmodiun berghei.
    Howells RE; Peters W; Thomas EA
    Ann Trop Med Parasitol; 1968 Sep; 62(3):271-6. PubMed ID: 5714954
    [No Abstract]   [Full Text] [Related]  

  • 7. The chemotherapy of rodent malaria. V. Dynamics of drug resistance. I. Methods for studying the acquisition and loss of resistance to chloroquine by Plasmodiun berghei.
    Peters W
    Ann Trop Med Parasitol; 1968 Sep; 62(3):277-87. PubMed ID: 5714955
    [No Abstract]   [Full Text] [Related]  

  • 8. Theory for the mechanism of chloroquine resistance in rodent malaria.
    Howells RE; Peters W; Homewood CA; Warhurst DC
    Nature; 1970 Nov; 228(5272):625-8. PubMed ID: 5474933
    [No Abstract]   [Full Text] [Related]  

  • 9. [New 6-aminoquinolines with antimalarial activity. Test results on schizontocidal and causalprophylactic effects in rodent- and avian malaria (Plasmodium vinckei, P. berghei and P. cathemerium)].
    Fink E; Nickel P; Dann O
    Arzneimittelforschung; 1970 Nov; 20(11):1775-7. PubMed ID: 5536991
    [No Abstract]   [Full Text] [Related]  

  • 10. Chloroquine effects on parasite and host membranes of intraerythrocytic Plasmodium chabaudi.
    Stübig H; Könoigk E
    Tropenmed Parasitol; 1981 Jun; 32(2):77-81. PubMed ID: 7256832
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Preferential action of chloroquine on Plasmodium within mature erythrocytes].
    Dei-Cas E; Slomianny C; Prensier G; Vernes A; Colin JJ; Verhaeghe A; Savage A; Charet P
    Pathol Biol (Paris); 1984 Dec; 32(10):1019-23. PubMed ID: 6393008
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The chemosensitivity of the rodent malarias--relationships with the biology of merozoites.
    Beauté-Lafitte A; Altemayer-Caillard V; Gonnet-Gonzalez F; Ramiaramanana L; Chabaud AG; Landau I
    Int J Parasitol; 1994 Nov; 24(7):981-6. PubMed ID: 7883449
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chemotherapy of rodent malaria: transfer of resistance vs mutation.
    Schoenfeld C; Most H; Entner N
    Exp Parasitol; 1974 Oct; 36(2):265-77. PubMed ID: 4606333
    [No Abstract]   [Full Text] [Related]  

  • 14. Effects of chloroquine on the morphology of the erythrocytic stages of Plasmodium gallinaceum.
    Aikawa M; Beaudoin RL
    Am J Trop Med Hyg; 1969 Mar; 18(2):166-81. PubMed ID: 5777732
    [No Abstract]   [Full Text] [Related]  

  • 15. Heme metabolism of Plasmodium is a major antimalarial target.
    Padmanaban G; Rangarajan PN
    Biochem Biophys Res Commun; 2000 Feb; 268(3):665-8. PubMed ID: 10679261
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chloroquine resistance and host cell hemoglobin catabolism in Plasmodium berghei.
    Wood PA; Rock LM; Eaton JW
    Prog Clin Biol Res; 1984; 155():159-69. PubMed ID: 6382314
    [No Abstract]   [Full Text] [Related]  

  • 17. Regulation of intracellular glutathione levels in erythrocytes infected with chloroquine-sensitive and chloroquine-resistant Plasmodium falciparum.
    Meierjohann S; Walter RD; Müller S
    Biochem J; 2002 Dec; 368(Pt 3):761-8. PubMed ID: 12225291
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chloroquine-resistant Plasmodium falciparum malaria in Vanuatu.
    Bowden DK; Bastien P; Douglas FP; Muir JW; Tambisari E
    Med J Aust; 1982 Dec 11-25; 2(12):561-2. PubMed ID: 6761561
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chloroquine-resistant malaria.
    Wellems TE; Plowe CV
    J Infect Dis; 2001 Sep; 184(6):770-6. PubMed ID: 11517439
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Malaria. Chloroquine makes a comeback.
    Vogel G
    Science; 2006 Nov; 314(5801):904. PubMed ID: 17095662
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.